Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

NCT05650866 is registered in ClinicalTrials.gov with Comphya Australia as lead sponsor.

NCT NCT05650866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05650866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Lead sponsor
Comphya Australia
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 19, 2023
Completion date
June 30, 2028
Enrollment
20 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction following radical prostatectomy